Background 1. Definition Fibroadenoma: Group of hyperplastic breast lobules composed of stromal and epithelial elements

Similar documents
ACRIN 6666 Screening Breast US Follow-up Assessment Form

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

BRCA1 and BRCA2 Mutations

Physical Exam & Associated Pathology Part VIII Breast & Female Pelvis

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Health Science Ch. 16 Cancer Lecture Outline

2. How are screening and diagnostic mammograms different?

2017 CMS Web Interface

Page 1 of 5. Fast Facts. CTC v.4; AJCC 7 th ed. Herceptin provided

WHAT IS HEAD AND NECK CANCER FACT SHEET

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Osteoporosis Fast Facts

Safety of HPV vaccination: A FIGO STATEMENT

Male patients with pain, swelling or erythema please refer to the Acute Painful Scrotum pathway Female patients

US Public Health Service Clinical Practice Guidelines for PrEP

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

Lyme Disease Surveillance in North Carolina

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Improving Treatment Rates of Cervical Precancers Detected through Visual Screening in Cameroon, West Africa.

NPCR CLINICAL EDIT CHECKS

Obesity/Morbid Obesity/BMI

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

Swindon Joint Strategic Needs Assessment Bulletin

Referral Criteria: Inflammation of the Spine Feb

Percutaneous Nephrolithotomy (PCNL)

Post Coital Bleeding

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Prostatitis - chronic - Management

Benefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016

Field Epidemiology Training Program

decreased when the man lies down. The varicocele cannot usually be palpated lying down.

GYNAECOLOGICAL PROBLEMS

CLINICAL MEDICAL POLICY

Sasan Dabiri, MD, Assistant Professor

Cardiac Rehabilitation Services

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

Indications and Limitations of Coverage and/or Medical back to top

Adult Preventive Care Guidelines

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

Υποτροπιάζουσες Περικαρδίτιδες: Τι νεότερο; Γεώργιος Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.

REFERRAL GUIDELINES Upper Gastro-Intestinal & Hepaticobilary

Completing the NPA online Patient Safety Incident Report form: 2016

INFERTILITY DIAGNOSIS

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

MRI LOWER EXTREMITIES IMAGING FACT SHEET. MRI Lower Extremities

ASSESSMENT OF PITUITARY FUNCTION IN PATIENTS WITH SERUM PROLACTIN LEVELS GREATER THAN 100 NG/ML*t

ALCAT FREQUENTLY ASKED QUESTIONS

Urinary tract infection (lower) - women - Management

Cancer of Unknown Primary (CUP) Pathways and Guidelines (v 2) London Cancer. April 2017

EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer

Chapter 6: Impact Indicators

Emergency Department Performance Measures

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Subject: Mohs Micrographic Surgery

Drug Therapy Guidelines

o Pathologic changes can be observed in majority of overhead athletes including those that are asymptomatic

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Most Frequently Missed Diagnosis: Retropharyngeal Suppurative Lymphadenitis

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

OTHER AND UNSPECIFIED DISORDERS

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado

DRAFT Policy for the Management of Ear Wax

Q&A. Collecting Cancer Data: Breast. Collecting Cancer Data: Breast 4/7/2011. NAACCR Webinar Series 1. Agenda

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

Chronic Fatigue Syndrome

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

2018 CMS Web Interface

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

Top 10 Causes of Disability

Hand Pain & Problems

What s your diagnosis? Signlament: 11 y MC Maltese Mix. Presenting complaint: Pollakiuria with hematuria.

MIDLAND MEMORIAL HOSPITAL Delineation of Privileges ORTHOPEDIC SURGERY

APA-accredited: YES NO X. Brown University. Stephen Salloway, M.D. (Primary Supervisor) Paul Malloy, Ph.D.

C-SAS.2 Small Animal Soft Tissue Surgery (A)

Annex III. Amendments to relevant sections of the Product Information

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

2017 CMS Web Interface

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

TITLE: Managing Menopausal Symptoms in Breast Cancer Survivors

Psychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen

LYME DISEASE (taken from 6/20/13)

Basic Thyroid Examination

CHEMOPREVENTION in BREAST CANCER

Acquired Optic Neuropathies

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Cancer in Primary Care

5.0: Rare Bleeding Disorders

Four categories which guide further evaluation

List of Preventive Care Services Covered at 100% for Non-Grandfathered Group Plans

Cambridge Breast Unit Protocols for anticoagulant management prior to breast or axillary biopsies or excisions.

2018 CMS Web Interface

Transcription:

Fibradenma Backgrund 1. Definitin Fibradenma: Grup f hyperplastic breast lbules cmpsed f strmal and epithelial elements Simple benign slid tumrs with glandular and fibrus tissue Cmplex Scleringadensis Ductal epithelial hyperplasia Epithelial Calcificatin Papillary apcrine changes Pathphysilgy 1. Pathlgy f disease Etilgy unknwn Hrmnal relatinship likely Increases in size Pregnancy Estrgen use Immunsuppressin May regress after menpause 2. Incidence, prevalence Mst cmmn benign breast tumr in wmen Mst cmmn breast lesin in adlescents 4 13-20% with multiple fibradenmas Mst cmmn between 15-35 y/ 8 N racial predilectin 2 3. Risk factrs fr breast cancer Hrmne use Alchl intake Adjacent prliferative disease Family histry f breast cancer 7 Diagnsis 1. Histry Nature and pattern f symptms Relatinship t menstrual cycles Timing f nset and subsequent curse Presence f and characteristics f nipple discharge r breast pain Hrmne use All prir treatments Past histry f similar prblem Fibradenma Page 1 f 5 5.21.11

2. Mrbidity/Mrtality Increased Risk f Breast Cancer 7 Cmplex Fibradenmas Relative Risk 3.10 Cmplex and family histry f breast cancer Relative Risk 3.72 Cmplex with benign prliferative disease in adjacent parenchyma Relative Risk 3.88 Simple Fibradenmas w/ family histry f Breast cancer N increased risk 3. Physical exam Inspect breast fr evidence f ulceratin r cntur changes Examine nipple Palpate in bth upright and supine psitins May appear as: Palpable val, freely mbile, rubbery masses, smth brders Size vary frm 1-15 cm Inspect chest wall, axilla, and neck 4. Diagnstic evaluatin N labratry testing necessary Diagnstic imaging Ultrasund - Preferred if distinct palpable mass present, age <30 y/ r pt pregnant Findings c/w fibradenma circumscribed hypechic val r rund mass with gentle lbulatins smth thin, echgenic pseudcapsule variable acustic enhancement hmgeneity Mammgram Use if palpable mass, >30 y/, r nn-pregnant Fibradenmas typically circumscribed val r rund masses which ccasinally have carse calcificatins In yung wmen with dense breast tissue, ultrasngraphy shuld be used vice mammgraphy t detect breast lesins (SOR C) 9 The USPSTF recmmends biennial screening mammgraphy fr wmen aged 50 t 74 years. Grade B recmmendatin (USPSTF) 6 MRI Fibradenmas typically smth masses with high signal intensity n T2 weighted images and enhancement with gadlinium Diagnstic criteria: Definitive diagnsis requires image guided bipsy Fibradenma Page 2 f 5 5.21.11

Differential Diagnsis 1. Simple r cmplex cysts 2. Hamartmas 3. Lipmas 4. Cystsarcmaphylldes 5. Lactatinal adenmas 6. Papillmas 7. Mucinus carcinmas 8. Medullary carcinmas 9. See als Breast masses Treatment 1. Management Simple fibradenmas diagnsed n clinical and radilgical exam, ptins include: Cre bipsy Cnfirm diagnsis with n further fllw up required, r Serial ultrasunds Lk fr changes in appearances every 6 mnths fr 2 years with excisin if changes ccurs, r Office-based cryablatin Further clinical experience and data n lng term fllw up are needed Interstitial laser therapy Current data inadequate fr safety and efficacy f this prcedure Rutine excisinal bipsy N supprting evidence (simple fibradenmas) Excisinal bipsy shuld be perfrmed in wmen with clinically suspicius lesins, r lesins that are equivcal n imaging, FNA, r CNB.(SOR C) 9 If increases in size r symptmatic, excisin is needed t rule-ut malignancy 9 Risk f scarring that hampers future mammgraphic and sngraphic interpretatin Cmplex fibradenmas diagnsed n clinical and radilgical exam Excisinal bipsy N further therapy after cmplete remval If dx f fibradenma uncertain: Aspiratin w/cytlgical evaluatin f aspirate, r Steretactic cre bipsy r ultrasund guided bipsy A histry f benign breast disease r a psitive family histry f breast cancer shuld nt be regarded as cntraindicatins t ral cntraceptive use (SOR A) 10 Fibradenma Page 3 f 5 5.21.11

Fllw-Up 1. Return t ffice Serial ultrasund Every 6 mnths fr 2 years in patients with simple fibradenmas Fllwed by regular screening thereafter Rutine screening Patients with simple fibradenmas and family Hx f breast cancer in first degree relatives Patients with cmplex fibradenmas after cmplete excisin Yearly mammgram and clinical exam by a physician Thse with a histlgical finding f atypical ductal r lbular hyperplasia in the fibradenma Fllw up breast exam in 4-6 weeks preferably pst menstrually Thse with nn palpable mass and negative imaging, r Nn dminant mass and negative imaging, r Dminant mass that reslved n aspiratin with pst aspiratin imaging remaining negative 2. Refer t specialist Pts requiring cre bipsy r aspiratin f breast mass Persisting dminant mass after aspiratin, all recurring cystic masses r bldy tap Pts with abnrmal imaging Pts with cmplex fibradenma requiring excisinal bipsy Pts with lbular r ductal hyperplasia with atypia n image guided bipsy Evidence-Based Inquiry 1. Fr a nn-lactating wman with breast inflammatin, is a trial f antibitics apprpriate befre imaging and/r bipsy? References 1. Diagnsis f breast disease. Institute fr Clinical Systems Imprvement Guidelines, 2005 Nv. Available at www.ngc.gv 2. Schnitt, SJ, Cllins, L.C. Pathlgy f benign breast disrders. In: Breast diseases, 4 th ed, Harris, JR, et al, Lippinctt, Philadelphia 2010. Page 69. 3. Interstitial laser therapy fr fibradenmas f the breast. Natinal Institute fr Clinical Excellence. 2005 June,. Available at www.nice.rg.uk 4. Greydanus,DE,Matytsina,LGains,M. Breast disrders in children and adlescents. Primary Care 2006; 33:455 5. El-Wakeel H, et al. Systematic review f fibradenma as a risk factr fr breast cancer. Breast. 2003 Oct; 12(5): 302-7. 6. USPSTF, Nv 2009 http://www.uspreventiveservicestaskfrce.rg/uspstf/uspsbrca.htm 7. Dupnt, WD, Page, DL, Parl, FF, et al. Lng-term risk f breast cancer in wmen with fibradenma. N Engl J Med 1994; 331:10 8. Carty, NJ, Carter, C, Rubin, C, et al. Management f fibradenma f the breast. Ann R CllSurgEngl 1995; 77:127. Fibradenma Page 4 f 5 5.21.11

9. Klein, Susan. Evaluatin f Palpable Breast Masses. American Family Physician/ 2005 May 1;71(0); 1731-1738. 10. Use f Hrmnal Cntraceptin in Wmen with C-Existing Medical Cnditins. Natinal Guideline Clearinghuse. June 2006 http://www.guideline.gv/cntent.aspx?id=10924&search=fibradenma Authr: Whitney Curtney, DO, United Hspital Center Prgram, WV Editr: Rbert Marshall, MD, MPH, MISM, CMIO, Madigan Army Medical Center, Tacma, WA Fibradenma Page 5 f 5 5.21.11